Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.
288 - If we are to conduct comparative analysis (our product vs. marketed products from the same category) to support a claim to be presented to HCP, what are the standards that the study and resutls should meet for PAAB to consider it acceptable?
-
I need a bit more info to provide an answer. Please clarify the following two parameters: the nature of the comparisoni.e. therapeutic comparison relating to efficacy/safety, pharmacoeconomic comparison, retention, format availability, other non-clinical features (e.g. receptor affinity/potency, MOA, preference, cosmetic/sensory attributes), etcÂ…the nature of the sourcei.e. a survey, a published clinical trial, product monographs, third party data, etcÂ…
